Tag Archives: GE Healthcare

April 2018—Roche and GE Healthcare will partner to develop and co-market digital clinical decision support solutions. The companies aim to develop a digital platform using analytics to provide workflow solutions and apps that support clinical decisions. This will allow the integration and analysis of in vivo and in vitro data, patient records, medical best practices, real-time monitoring, and the latest research outcomes.

Feb. 13, 2018—Inspirata, a biotechnology and software company, announced it has acquired Pittsburgh-based Omnyx from GE Healthcare. Omnyx’s flagship digital pathology software, Dynamyx, aims to enhance the pathology workflow by providing new channels for collaboration and tools to boost efficiency. The software is CE-marked in Europe and licensed by Health Canada for in vitro diagnostic use. “The acquisition of Omnyx ...

April 2014—BioMérieux’s molecular diagnostic test THxID-BRAF has been added to the offerings provided by Clarient, a GE Healthcare company.

May 2014—Clarient Diagnostic Service, a GE Healthcare company, upgraded its fluorescence in situ hybridization technologies to improve virtual analysis of test results for leukemia, lymphoma, myelodysplastic syndrome, and myeloma.